Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 12 studies | 29% ± 8% | |
endothelial cell | 11 studies | 22% ± 6% | |
glutamatergic neuron | 10 studies | 36% ± 25% | |
oligodendrocyte | 10 studies | 36% ± 12% | |
GABAergic neuron | 6 studies | 37% ± 21% | |
oligodendrocyte precursor cell | 5 studies | 29% ± 10% | |
neuron | 4 studies | 26% ± 10% | |
epithelial cell | 4 studies | 31% ± 9% | |
respiratory goblet cell | 4 studies | 21% ± 5% | |
goblet cell | 4 studies | 36% ± 25% | |
ionocyte | 3 studies | 28% ± 6% | |
retinal ganglion cell | 3 studies | 43% ± 15% | |
club cell | 3 studies | 19% ± 3% | |
capillary endothelial cell | 3 studies | 20% ± 5% | |
interneuron | 3 studies | 49% ± 23% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 9 studies | 35% ± 19% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 5064.10 | 1445 / 1445 | 99% | 53.52 | 182 / 183 |
intestine | 100% | 3140.15 | 966 / 966 | 99% | 43.43 | 524 / 527 |
prostate | 100% | 3227.90 | 245 / 245 | 99% | 43.29 | 498 / 502 |
thymus | 100% | 3868.62 | 653 / 653 | 99% | 63.48 | 600 / 605 |
stomach | 100% | 2502.69 | 359 / 359 | 99% | 40.15 | 283 / 286 |
lung | 99% | 3392.52 | 575 / 578 | 99% | 43.48 | 1145 / 1155 |
breast | 100% | 2973.91 | 459 / 459 | 98% | 48.58 | 1095 / 1118 |
adrenal gland | 100% | 6996.12 | 258 / 258 | 97% | 68.54 | 223 / 230 |
brain | 99% | 4556.43 | 2613 / 2642 | 98% | 37.05 | 688 / 705 |
bladder | 100% | 2341.24 | 21 / 21 | 96% | 31.84 | 486 / 504 |
uterus | 98% | 1771.31 | 167 / 170 | 90% | 30.43 | 411 / 459 |
pancreas | 90% | 1145.61 | 294 / 328 | 98% | 38.22 | 174 / 178 |
kidney | 99% | 1712.48 | 88 / 89 | 87% | 20.60 | 784 / 901 |
skin | 83% | 3982.46 | 1497 / 1809 | 87% | 28.18 | 409 / 472 |
ovary | 54% | 594.58 | 97 / 180 | 95% | 23.27 | 410 / 430 |
spleen | 100% | 2243.59 | 241 / 241 | 0% | 0 | 0 / 0 |
adipose | 100% | 2367.54 | 1199 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 39.45 | 44 / 45 |
heart | 94% | 1432.39 | 806 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 18.78 | 27 / 29 |
blood vessel | 93% | 1379.93 | 1237 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 35% | 880.84 | 325 / 929 | 0% | 0 | 0 / 0 |
liver | 2% | 17.92 | 5 / 226 | 28% | 6.29 | 115 / 406 |
muscle | 20% | 164.81 | 157 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 13% | 1.67 | 10 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042590 | Biological process | antigen processing and presentation of exogenous peptide antigen via MHC class I |
GO_0016020 | Cellular component | membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005515 | Molecular function | protein binding |
Gene name | MFSD6 |
Protein name | Major facilitator superfamily domain-containing protein 6 (Macrophage MHC class I receptor 2 homolog) Major facilitator superfamily domain containing 6 |
Synonyms | MMR2 |
Description | |
Accessions | ENST00000445546.1 ENST00000432036.5 ENST00000444317.1 C9JJH2 ENST00000281416.11 C9IYL1 ENST00000417958.5 H7C0X2 H7C284 C9J134 Q6ZSS7 ENST00000412482.1 C9JAZ7 ENST00000392328.6 ENST00000434582.5 |